Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 14 unusual trades.
Delving into the details, we found 78% of traders were bullish, while 21% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $610,329, and 7 were calls, valued at $372,884.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $160.0 for Novo Nordisk, spanning the last three months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $100.0 to $160.0, over the past month.
Novo Nordisk 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | PUT | TRADE | BULLISH | 06/21/24 | $3.3 | $3.2 | $3.2 | $130.00 | $256.0K | 2.1K | 977 |
NVO | PUT | SWEEP | BULLISH | 06/21/24 | $5.95 | $5.8 | $5.8 | $135.00 | $154.8K | 716 | 286 |
NVO | CALL | TRADE | BULLISH | 01/17/25 | $5.3 | $5.15 | $5.28 | $160.00 | $132.0K | 1.5K | 251 |
NVO | CALL | SWEEP | BULLISH | 06/21/24 | $5.0 | $4.95 | $5.0 | $130.00 | $65.0K | 8.6K | 159 |
NVO | PUT | SWEEP | BULLISH | 03/21/25 | $9.3 | $9.25 | $9.3 | $125.00 | $43.7K | 601 | 47 |
About Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Following our analysis of the options activities associated with Novo Nordisk, we pivot to a closer look at the company's own performance.
Present Market Standing of Novo Nordisk
- With a trading volume of 859,538, the price of NVO is down by -1.46%, reaching $131.1.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 83 days from now.
What The Experts Say On Novo Nordisk
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
金融巨头对诺和诺德采取了明显的看涨举动。我们对诺和诺德(纽约证券交易所代码:NVO)期权历史的分析显示了14笔不寻常的交易。
深入研究细节,我们发现78%的交易者看涨,而21%的交易者表现出看跌倾向。在我们发现的所有交易中,有7笔是看跌期权,价值610,329美元,7笔是看涨期权,价值372,884美元。
目标价格是多少?
在评估了交易量和未平仓合约之后,很明显,主要市场走势者正在关注过去三个月诺和诺德在100.0美元至160.0美元之间的价格区间。
交易量和未平仓合约趋势
检查交易量和未平仓合约为股票研究提供了至关重要的见解。这些信息是衡量Novo Nordisk期权在特定行使价下的流动性和利息水平的关键。下面,我们简要介绍了过去一个月诺和诺德重大交易的看涨期权和未平仓合约的趋势,行使价区间为100.0美元至160.0美元。
Novo Nordisk 30 天期权交易量和利息快照
值得注意的期权活动:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
NVO | PUT | TRADE | BULLISH | 06/21/24 | $3.3 | $3.2 | $3.2 | $130.00 | $256.0K | 2.1K | 977 |
NVO | PUT | SWEEP | BULLISH | 06/21/24 | $5.95 | $5.8 | $5.8 | $135.00 | $154.8K | 716 | 286 |
NVO | CALL | TRADE | BULLISH | 01/17/25 | $5.3 | $5.15 | $5.28 | $160.00 | $132.0K | 1.5K | 251 |
NVO | CALL | SWEEP | BULLISH | 06/21/24 | $5.0 | $4.95 | $5.0 | $130.00 | $65.0K | 8.6K | 159 |
NVO | PUT | SWEEP | BULLISH | 03/21/25 | $9.3 | $9.25 | $9.3 | $125.00 | $43.7K | 601 | 47 |
关于 Novo Nordisk
诺和诺德拥有全球品牌糖尿病治疗市场约三分之一的份额,是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦,生产和销售各种人用和现代胰岛素、注射型糖尿病治疗药物(如 GLP-1 疗法)、口服抗糖尿病药物和肥胖疗法。Novo还有一个生物制药板块(约占收入的10%),专门研究血友病和其他疾病的蛋白质疗法。
在分析了与Novo Nordisk相关的期权活动之后,我们将转向仔细研究公司自身的表现。
诺和诺德目前的市场地位
专家对诺和诺德的看法
在过去的30天中,共有1位专业分析师对该股发表了看法,将平均目标股价定为160.0美元。
与仅交易股票相比,期权是一种风险更高的资产,但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。